Search the KHIT Blog

Friday, April 1, 2011

Springtime for Meaningful Use

CMS will begin taking MU attestations for year one incentive fund remittances on April 18th. I would expect that they will make a big PR play on it to help entice the laggard into participation.
___

INTERPRETATION QUESTIONS REMAIN

I posted this on our HITRC earlier in the week. Have yet to get an answer:
Menu set item for "structured labs" (verbatim from the Final Rule, pg 224)

"More than 40% of all clinical lab tests results ordered by the EP or by an authorized provider of the eligible hospital or CAH for patients admitted to its inpatient or emergency department (POS 21 or 23) during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in certified EHR technology as structured data."

Then, denominator & numerator specs on Final Ruie pg 133:
  • "Denominator: Number of lab tests ordered during the EHR reporting period by the EP or authorized providers of the eligible hospital or CAH for patients admitted to an eligible hospital’s or CAH’s inpatient or emergency department (POS 21 & 23) whose results are expressed in a positive or negative affirmation or as a number.
  • Numerator: The number of lab test results whose results are expressed in a positive or negative affirmation or as a number which are incorporated as structured data."
___

Am I correct to interpret this as every individual analyte parameter returned from a lab order going into the numerator? e.g., my primary doc routine f/u visit labs typically include CBC, UA, lipid panel, metabolic panel, PSA – dozens of individual analyte results each time. Every individual analyte assay is a "test" providing POS/NEG or quantitative data for a clinical decision regarding a patient, not just the parent panel in the order.

It seems to me to be in the provider's advantage to get numerator credit for every structured data "result" within a lab order (beyond the outright clinical decision utility of every analyte metric). But, I'm not sure how this will be construed.

I'm betting that this numerator specification will have to be re-written to say something like this:
  • "Numerator: The number of lab orders whose returned results are expressed in positive or negative affirmations or as numbers which are incorporated as structured data for at least one analyte finding."
The reason I say that owes to having looked at the way the e-MDs certified version reports it: "# of provider lab orders (+/- or numeric results) incorporated as structured data."

"orders," not "tests"

What constitutes the "order"? Everything the doc checks off on the lab sheet or CPOE entry, or every subsidiary parameter assessed by the lab pursuant to the aggregate lab request?

This is but one example of remaining MU interpretation issues.

___

THE ONC 2011 - 2015 STRATEGIC PLAN


An interesting read. Click the title above to go to an ONC page containing summary information, a link to the PDF document, and now-accruing public comments at the bottom (there are 36 as I post this, including a number of very good ones). Have your say should you wish. Public review and comment runs through April 22nd.

I will be interested in particular in the "usability" proffer, given what I have posted on this blog thus far on the topic (see pp. 13-14):
Strategy I.A.9: Encourage and facilitate improved usability of EHR technology. The government is collaborating with industry and researchers to improve the usability of EHRs. The usability of EHRs is considered a key barrier to meaningful use and adoption. NIST is developing a set of objective and standardized criteria (standards and test methods) that can be used to evaluate and improve the usability of health IT systems. NIST has released a Common Industry Format (CIF), a standard for developers to report usability test findings and demonstrate evidence of usability in their products in a format that allows for independent evaluation of a single product and comparison across multiple products. NIST is developing guidance and tools for RECs and professional societies on available tools and resources to incorporate concepts of usability in selecting and implementing EHR systems. AHRQ is developing toolkits that medical practices can use to assess the usability of EHR systems and assess the redesign workflow. In addition, AHRQ conducted research and convened industry workgroups that provide perspectives on what constitutes usability and how to systematically improve the usability of EHRs.

ONC has directed one of its four Strategic Health IT Advanced Research Projects (SHARP) (see Strategy V.B.2) to further EHR usability through better cognitive and user-centered design. In addition, ONC is working with private sector groups to encourage the collection of usability information and its dissemination to vendors and consumers through mechanisms they can trust.

A lot to accomplish in a short time.
___

ERRATUM:
"WORKFLOW" WHEN YOU CUT AWAY ALL THE JARGON CRAP

LOL. Click the image to enlarge. When I go into the mostly small primary care ambulatory clinics I serve and bring up "workflow," I usually get the MEGO blank stares. This is from a booklet I'm assembling for my REC to try to cut to the chase and sell the concept to those lacking any clue or interest (i.e., most of them). Irrespective of the nominal swimlanes and/or nested complexity of any process, this is really the core logic.

UPDATE

More on workflow. Just got permission from the California Health Care Foundation to use in my nascent document a couple of workflow graphics contained in a recent paper they published entitled "Workflow Analysis: EHR Deployment Techniques." (PDF, author, S.A. Kushinka, MBA, Full Circle Projects, Inc.)

Rx refill request, pre- and post EHR deployment
(click either image below to enlarge):



  • Pre EHR, 15 steps between begin and end, shortest path, 13 steps;
  • Post-EHR, 5 steps between begin and end, shortest path, 3 steps.
Beyond the reduction in the number process steps per se (which should yield faster task completion times), it should be noted that, all other things being held equal, every additional task step in a process increases the probability of error (unless everything goes perfectly every time). Additionally, nearly all of the pre-EHR tasks are substantively physical in nature (related to chart and form chasing and pushing), while those following EHR deployment involve much less physical, more efficient EHR interaction.

Thanks, Dawn Weathersby, MSN, RN*, CHCF, and Mr. Kushinka.
*UPDATE: Small world. I probably could simply have used those two Rx workflow graphics above under "Fair Use," but I figured it only polite to ask permission. The author of the CHCF paper, S.A. Kushinka said "yeah, no problem, but I'll copy my contact at CHCF." That person emailed me back to also say "yeah, no problem, just give us a cite." I also sought out Dawn Weathersby, whose name appears in the graphics. Her name had sounded familiar. Turns out she once worked for Lumetra, the then-California QIO, within the federal DOQ-IT program that I had also worked within back during 2005-2007, and these workflows were part of DOQ-IT ("Son of REC") stuff on her part, and are consequently public domain. Dawn is now Director of Healthcare Product Strategy for Oracle. I heard from her today, so I have to give her a shout here.
___

VERILY, FTE?

I was on a HITRC "Privacy & Security CoP" call/webinar today. I snipped these (below) out of their slides.


A Meaningful Use HIPAA-compliant "Privacy and Security Audit" (replete with remediation of any deficiencies uncovered) is one of the Core Set requirements for Stage One Year One attestation (one of the 15 core criteria). I'll be really charitable here and just round up to an expected 6 REC hours per audit assistance.

Our REC is to engage about 1,500 providers. OK, that's 4.5 FTE (9,000 hrs) just to get them through this one measure. Along with all the other Meaningful Use adoption support hand-holding.

Yikes.
___

More to come...

Tuesday, March 15, 2011

The Ides of our forced REC March


A year ago I was eyeball deep in the Meaningful Use IFR, trying to wrap my head around all of the voluminous detail (much of it explicitly "tentative" at the time), and scrambling from training meeting to training meeting, as we prepared to launch our hyper-ambitious provider recruitment campaign (which continues unabated to this day. I just returned from signing up a primary care doc who is about to upgrade to eClinicalWorks 9.0).

More thoughts to come, in no particular order (this is, after all, just a blog, and pretty much an episodic one-draft evening and weekends when-I-have-the-time effort at that)...
___

BOSTON CONSULTING GROUP
ON THE PCAST REPORT

Recall that I've previously cited the PCAST Report at some length. I read this recently on The Health Care Blog.

Realizing Value from Health IT: A BCG Response to the PCAST report

A blended Money Quote:

"...technical policy, standards, and incentives are necessary but not sufficient to drive meaningful use...Ultimately the business structure, not the technical architecture, of the industry will determine which cost, quality, and access objectives are feasible in health care..."

Which, of course, goes to policy reform. And, while policy reform is above my nominal pay grade (my being a mere Meaningful Use technical assistance grunt), well, some things are in fact joined at the hip. If MU is to eventually comprise more than simply "Clicking for Cash," rational policy reform will be at its core. JMHO.

Apropos of all this:

(Click above for the article.)

___

BACK TO MU TECHNICAL ASSISTANCE ISSUES

An example I saw today on our HITRC (Health Information Technology Research Center), a Q & A between two MDs.

Clinical Summary Measure Workflow & Issues

Q: Any advice from folks who have started implementing clinical summaries with EHR’s? We’re running into some concerns about the logistics of clinics getting clinical summaries to 50% of their patients. I think many clinics & REC’s do not yet fully realize the workflow problems that this measure will create.

First, the items required to be included are pretty extensive: Patient Name, Provider’s office contact information, Date and location of visit, Reason for the visit, Symptoms, Updated medication list and Summary of current medications, Updated vitals, Procedures and instructions based on any discussions that occurred during the visit, Lab / diagnostic test orders, Lab / test results (if received within 24 hours after visit), Updates to the problem list (if applicable), Immunizations or medication administered, Summary of topics covered during visit, Time and location of next appointment / testing (if scheduled), Recommended next appointment (if not already scheduled), Other appointments / testing patient needs to schedule (including contact information)

Some of this will not be available until clinicians have finished their note. This will result in a bottle neck for many clinics because clinicians frequently finish notes after patients have left the office. Finishing notes is often done during the slack time in the clinic day (e.g., while waiting for lab, waiting for a late patient, or at the end of the clinic session). If a clinical summary is needed, it may require the clinician to stop their office flow to finish the visit note so that the summary can be generated before the patient checks out.

Second, the clause “Lab / test results, if received within 24 hours after visit” means that the patient may need to be given a 2nd updated summary when their lab results come in. Many labs these days are received by clinics with lab interfaces within 24 hours, so almost every patient with a lab draw will need to be given an updated summary if they were already given a summary at checkout. One way around this is to send out the clinical summary 24 hours after the visit to avoid 2 summaries being given. This would require thousands of dollars of extra postage unless the clinic utilizes secure e-mail for its lab results or a web portal (was this measure a back door method of requiring clinics to purchase a web portal for stage 1?).

Lastly, as a physician, I see this as the single hardest measure to meet as it will require a significant amount of staff time to achieve. The rationale & intent of the measure is very solid. With my EHR, I often opened a Word document to type out a “To Do” list for my patients (which I then cut and pasted into the end of my EHR’s progress note). It served as a helpful reminder for my patients, especially the elderly (often printed in 16 or 18 point font so they could read it). The measure as written, however, is very strict and detailed. What will happen if we see many of our clinics missing this measure by 10-20% at 90 days when they hoped to attest for MU? Since MU incentives are all or none (if you miss 1 core measure by 1%, you get $0), what if large numbers of clinics miss out on MU incentives due to missing this one measure? Will there be a large number of irritated clinics missing this measure who make a very public outcry? Will ONC be able to backtrack on this number? (This sort of thing happens periodically with QIO grants when the measure set was unrealistic and was later thrown out, however these things happen quietly away from media eyes.)

Hopefully this isn’t coming across as too negative, but it’s something to start thinking about. Any advice would be appreciated.
___

A: The only realistic way to achieve this is via a patient portal or personal health record. I do realize that these are not widely deployed. The nature of the requirements and workflow dance require asynchronous communication. I am curious how many of the EMR practices or organizations that RECs are working with have implemented these electronic tools for patients. In our REC region, large physician practices on an EMR for 3 years or more are implementing Patient Portals. Hospitals have been slower. There is some uptake of PHRs, but so far a disturbing lack of sponsorship. The state of Indiana HIE plan does have PHR connectivity to HIE planned in the next 1-2 years.

Interesting. And that ("Visit Summaries," 170.304.h) is generally considered to be one of the easier measures.
___

OFF TOPIC, A PERSONAL ASIDE

I've been closely following the news out of Japan since last Friday in mute horror and dismay. The continuing nuclear disaster added to the earthquake and tsunami catastrophe just leaves you speechless. It reminds me of a time in my life 25 years ago.
In the spring of 1986 I was managing a Radiological Environmental Monitoring Program database and reporting system (REMP) I’d developed for the environmental radiation lab in Oak Ridge where I worked. One of our clients was Perry Nuclear of Ohio (they intended to build a nuke plant there). The REMP stuff comprised an ongoing environmental baseline study via which to establish natural radionuclide levels across the breadth of matrices within a 5 mile radius of the proposed plant site — soils, vegetation, water, milk from local cows, all manner of biota, and the air.

The air filter analyses always came back “below LLD” (Lower Limit of Determination, i.e., in this case “LT 0.04 pCi/cu.m." (less than 4-100ths of a trillionth of a Curie). I had a macro code snippet that simply populated that field with that update ongoing.

One week after Chernobyl we had elevated positive lab readings across all air filter locations. I-131. Given its 8.05 day half-life, it descended back down to below LLD after about 5 weeks.

Nonetheless, it was a bit creepy.

Other, heavier radionuclides like Cs-137 were blown all over the arctic regions. Scientists are probably STILL studying biota uptake and rad migration on a lot of this stuff.
I confess, I’m not a big fan of using intrinsically toxic unstable heavy elements to boil water for turbine steam to produce general electricity. The only net upside of nuke is the absence of greenhouse gases at the point of power production (and, in fairness, that is indeed a significant benefit). But, for that you trade all the other externalities -- e.g., the destructive pit mining, the long-term waste, and the requisite Nuclear Security State.

Neither do I buy the False Dilemma of “either nuke or coal.” See one of my old blog posts, "0.0143%"

For now, I just hope they can get those crippled Japanese plants under control. Even absent a Chernobyl-esqe event, it is pretty clear at this point that they now have a set of permanently damaged reactors that will end up in a fate similar to that of Three Mile Island Unit 2 (which cost an initial billion dollars to safely sequester). Talk about "sunk costs."

My heart goes out to the people of Japan. They'll be decades recovering from this.
___

OK, HERE'S A POTENTIAL NEVADA EHR LAND MINE

Just got copied on an email from someone in our NV state DHHS:
"Found out from our Pharm Board that in NV, an e-prescribing system must be approved by the Board before it can be used."
What?

Here's the link to the Nevada regulation (NAC 639.7102).

The email went on to list NV "approved" e-Rx systems:

  1. Allscripts, LLC
  2. Alteer
  3. BioMedix Vascular Solutions, Inc./TRAKnet DPM
  4. Cardinal Health Nuclear Pharmacy Services
  5. Catalis Inc.
  6. DrFirst Inc.
  7. e-MDs, Inc
  8. GE Healthcare
  9. Greenway Medical Technologies
  10. H2H Solutions, Inc. (H2H Digital Rx)
  11. Life-File
  12. MeridianEMR, Inc.
  13. McKession
  14. MedPlus
  15. MicroMD by Henry Schein Medical Systems
  16. MinuteClinic
  17. Misys Healthcare Systems
  18. Mountain Medical Technologies, Inc.
  19. Netsmart Technology
  20. NewCrop, LLC
  21. NextGen Healthcare
  22. Renown Health
  23. RxNT
  24. Sage Software Healthcare Division
  25. SRSsoft
  26. SuiteMed + Meditab Software
  27. SureScripts, LLC
  28. University Medical Center of Southern Nevada Outpatient Pharmacy
OK, as of today there are a total of 331 ONC certified ambulatory EHRs alone, 233 of them listed as "complete" systems (which by definition include e-Rx). There are a lot of big players that are not among the foregoing 28 Nevada "approved" e-Rx systems -- e.g., eClinicalWorks, a top-tier product (and the one most used to date among our REC clients) is not on this list.

Does federal law and regulation (and subsequent ONC certification) trump state law on this? Or, are many NV providers essentially in violation of the law here? Wow.

Now, #27, "SureScripts" is on the list, and clinics doing e-Rx typically transmit via their SureScripts interface accounts, so maybe that suffices by proxy. But, that would beg the question of why, then, have the other vendors on "the list"?


Someone needs to clarify this ASAP.
___

SPEAKING OF Rx

Last Sunday, on CBS' "60 Minutes"

“…counterfeit medications are not just being sold on the Internet. They are also making their way into mainstream pharmacies and hospitals. FDA Commissioner Margaret Hamburg says that while the vast majority of our drug supply is safe, there's reason for concern.

"You know, we don't really know the full dimensions of the problem. But, we do know that in certain countries somewhere between 30 and 50 percent of really important drugs for health are, in fact, counterfeit," Commissioner Hamburg said.

"How does all this increase in counterfeit drugs around the world affect the United States?" Gupta asked.

"Just consider that 40 percent of drugs taken in this country come from other countries; 80 percent of the active pharmaceutical ingredients in drugs taken in this country actually come from other countries," Hamburg said.

Even if the prescription medications are manufactured in the United States, the raw ingredients often come from overseas, through a complicated web of suppliers and distributors - and are increasingly vulnerable to counterfeiting…”
___


When we start doing large scale CER, to what extent might fake meds mislead us regarding "patient Rx compliance" and drug efficacy? e.g., Mr. Jones swears he's been religiously taking his 40 mg Simvastatin, but his lipids remain abnormally out of parameters.
___

More to come...

Sunday, February 27, 2011

Poof! Where did THAT year just go?

Wednesday March 2nd will be my first year anniversary back with HealthInsight, this time amid the REC initiative. The developments keep coming fast and furious, with accelerating pace. There will continue to be no shortage of things to ponder and post on (e.g., how about this? "The Connected Patient: Charting the Vital Signs of Remote Health Monitoring" [PDF] i.e., anytime/anywhere telemetry -- or, as the more paranoid might say, "ObamaCare medical surveillance").

Last week I was pleased to be asked to give a presentation to a class of med students at Touro University. My PPT deck is here. My opening slides below...



LOL. I took a big canvas shopping bag full of "props" with me for some ancillary IT-related Show & Tell. Told the kids I felt like Carrot Top as I rifled through it. Below, a couple of my props, my way expensive 1986 IBM-XT Seagate 20 megabyte hard drive (yeah, I took the drive cover off, it's just a museum piece now), along with my company Blackberry, and (bottom right) a freebie 2 gigabyte USB flash drive I acquired at some EHR event last year (100 times the capacity of my old disk drive, cheap enough to give away nowadays).


My Medical Director Dr. Bill Berliner had come along to give some follow-on remarks (I jokingly introduced him as "my Iraqi Minder"). He picked up my old hard drive prop and told the students about the time when he was a med student, and got to tour the UNIVAC computer site -- which occupied an entire building.

More to come, including the possible ACO/PCMH/"payment bundling" implications of the dust-up now making the rounds about the "RUC."

 Jeez... Click the graphic above for the source (PDF, American College of Radiation Oncology).

Also, recent wisecracks about the Meaningful Use program becoming merely "Clicking For Cash" (it gives me no pleasure to have to admit that the phrase has a good bit of resonance).

___

MONDAY MORNING UPDATE


From BNet "Jobs Are Plentiful in Healthcare — the Only Question is For How Long"

Department of redundant occupations department

Now let’s suppose, for a minute, that accountable care organizations emerge and begin to take financial responsibility for care in Michigan and other parts of the country. If these ACOs pay hospitals and doctors from an annual budget, they’ll need experienced accountants and people who know how to run information systems. But billers and coders will be unnecessary. In other words, an army of healthcare workers — perhaps more numerous than clinicians — could become redundant.

On the other hand, other categories would grow in importance. ACOs would need far more care managers and patient educators than we have today. And health IT would continue to add positions as it became woven into the fabric of health care. It’s already doing so. As Secretary of Health and Human Services Kathleen Sebelius pointed out in a keynote speech at a recent Orlando conference, “Health IT is one of our most promising new frontiers.”

She’s right, and more investors are committing to health IT as providers gear up to show “meaningful use” and garner up to $27 billion in government incentives. While it’s unclear how many new are jobs being created, HHS is providing money to community colleges to train up to 10,000 new IT technicians per year...
___

ERRATA
INTERESTING INTERACTIVE WEBSITE



Adroitly using health data...
___

FINALLY,
AN EHR MEANINGFUL USE
USER MANUAL


[Neither an express nor implied endorsement of this product, btw]

Monday evening, Feb 28th. We were just given access to an eCW ONC-certified version (9.0) remote desktop "sandbox" via which to kick the product's tires and learn our way around in order to better serve our REC providers, accompanied by a thorough 241 page PDF file instruction manual replete with workflow steps and screen shots. This will really help us to assist our REC clients on this particular EHR platform.

But...

When I first logged in and searched out one of the simpler MU compliance criteria ("Record Smoking Status," regarding which I've posted before), The NIST-specified six mutually exclusive response options were not there (in the default Social History template). Instead were simply "current smoker," "former smoker," and "never smoker."

Well, here's why (pg 45 of the manual):

Configuring Tobacco Use Structured Data Items

The appropriate Structured Data items must be properly mapped in order to record a patient’s tobacco use from the Progress Notes.

Note: In order to map tobacco use Structured Data items, they must first be created in the local system. For more information, refer to the section titled Creating Smoking Status Structured Data Items on page 169.

IMPORTANT! These Structured Data items are automatically mapped for new installations of eClinicalWorks. Only existing clients that are being upgraded need to configure Structured Data items...

OK. In other words, unless you're an eCW client buying 9.0 new (either converting from paper or from a different system), there's some onsite MU conversion setup data mapping to do by the client in advance of your attestation period (while the database upgrade aspect of this makes perfect sense, eCW doesn't do this for you). I'm still going through the manual to determine what other setup scut work lurks with respect to other MU criteria (one cautionary thing I've noted is that they list five different navigation paths for doing CPOE).

In fairness, notwithstanding the potential hassle factor here, overall this really is a valuable MU user guide -- the sort of thing that every ONC-certified vendor needs to supply to their clients (if you've read all of my posts you may recall that I noted previously that I would have made such a condition of certification).
___

POLICY STUFF: THE SCARY ACO
(from "THE HMO IN YOUR FUTURE")

'ACOs have been called “HMOs on steroids.” They will have capitated payments and, like the traditional HMO, the ACO will get to keep any money it doesn’t spend. But the organization will also incorporate all the latest fads in health policy: electronic medical records (EMRs), pay-for-performance (P4P) incentives, quality report cards, etc.'

HIT is a "fad"?
'Evidence-based policy would admit ignorance about what works and why, and would let a thousand flowers bloom. It would pay more for low-cost, high-quality care, regardless of how it is achieved.'

OK, I see, we don't know what constitutes clinical quality ("what works" -- not that I wholly disagree, but that's the point of pushing out HIT/HIE), but, like obscenity, we'll somehow know it when we see it. But, only, if it comes out of the for-profit sector -- which, of course, will magnanimously and freely promulgate its findings, notwithstanding the otherwise differential "business intelligence" value of the data.

 
MARCH 2nd UPDATE APROPOS OF ACOs and HIE

From FierceHealthIT:

Insurance companies' leap into HIE field will change health IT

...David Classen, MD, senior partner at consulting firm CSC, says that health plans are "looking at their future business model under healthcare reform." They view health information exchange (HIE) as an implementation tool for the value-based reimbursement methods that are coming, he says. Accountable care organizations (ACOs) also will be a big issue, and Classen expects hospitals to partner with health plans to create ACOs. Health plans have core competencies that most providers lack but will need for ACOs, such as the ability to analyze data and manage care, he notes.

Steve Tolle, senior vice president of provider markets for Ingenix, states that United's desire to partner with ACOs and to help providers form these organizations are among the reasons for Ingenix's acquisition of Axolotl. The company's purchases of other firms like Lighthouse MD (now CareTracker), Picis and A-Life similarly reflect its desire "to get close to the doctor and hospital workflow."

Tolle points out that Ingenix can bring "payer analytics" to bear on ACOs, helping them with care coordination and management. Axolotl will supply clinical data that can be analyzed and used in decision support. He adds that doctors need not fear that their patient data will be made available to United. Ingenix serves many payers and understands how to maintain data security, he says...
Think about all that.
___

MEANINGFUL USE, HIT/HIE, AND "PRIVACY"

 

"Patient privacy safeguards are woefully missing from initial draft criteria for Stages 2 and 3 of meaningful use, according to Deborah Peel, M.D., founder of the Patient Privacy Rights organization."
Interesting. I've been following "privacy" issues since before graduate school. See here, and here, as well. Ironic, in a way, given that I'm rather public; I've had the same web address and associated core email address since I was in grad school (1993-98), and given that I have both MySpace and Facebook pages. And, moreover, since I willingly revealed some very personal information in my painful web essay "1 in 3."

What are the legitimate concerns?

Some ought be obvious. A for-profit health insurance company still wants to find every possible legally defensible reason for disqualifying you from coverage (even after they've started taking your money). A prospective employer wants to likewise learn of your possible "dirt" (even if it cannot be substantiated). In a world still of ~five applicants for every available position in the U.S., odds of your possibly becoming "false positive" collateral damage, well, that's your problem, given the reality of your having no substantive recourse should they get it wrong (or even your unlikely awareness of the fact that they got it wrong). More mundanely, marketers of every stripe are looking to more effectively sell you stuff. Are you an indentfiable prospective statins, cholesterol, diabetic, PAD, "erectile dysfunction" (or other "worried well") customer, etc?

More on all of this shortly. For now, Google "Moral Hazard" and "Adverse Selection." You can also Google "Deborah C. Peel" and "Latanya Sweeney," the latter of whom is widely notable for her claim (published, no less, in "Scientific American" some years ago) that all she needs is your gender, date of birth, and ZIP code to have a better than 80% chance of identifying you.
___

HIT "USABILITY" UPDATES IN THE WAKE OF HIMSS11

First, from an interview with ONC's
Farzad Mostashari, MD, deputy national coordinator for health IT:

Q: How can ONC and the Centers for Medicare & Medicaid Services (CMS) enforce usability of EHRs? It shouldn't be so complicated that it takes extensive training and refreshers every six months to make EHRs work.

A: I don’t think we should set standards for what a user interface looks like. You don’t want government telling you what it should be. We need more transparency, with agreed-upon metrics for measuring usability first. That’s what we’re doing this year. By next year's HIMSS, there will be--as a result of an open process with industry participation and comments--some initial guidelines and metrics around aspects of usability and measurability. We need to get the current systems to have incentive for usability and transparency. We’ve gone too far not to have some guidelines.
Nothing exactly radical there. I've commented on "usability" issues before (see, e.g., my January 2nd, 2011 post). It 's a net good thing that they're finally paying some attention.

Then there was this, reported by John Moore over at The Health Care Blog:

Some Miscellaneous HIMSS Snippets:
Much to the chagrin of virtually every EHR vendor at HIMSS (still far too many and I just can’t even begin to figure out how they all stay in business) Chuck Friedman of ONC announced in his presentation on Sunday that they are looking into usability testing of EHRs as part of certification process [PDF]. Spoke to someone from NIST who told me this is a very serious consideration and they are putting in place the necessary pieces to make it happen.
OK. But, look at this slide of Dr. Friedman's...
 Your tax dollars at work.

WHAT?
I'm sorry, all attempts at (duly "branded") Powerpoint cutesy-ness aside, that is just flat wrong. ("Rigorability"? LOL.)

Another beauty from his presentation: "End users of health IT will ideally form a seamless cognitive and psychomotor bond with the technology."

Yeah, "we are all The Matrix."

 Or, how about "fighter jet and pilot become One"?

In fairness, I wasn't there, and there's no YouTube of his presentation, so maybe it was pretty good overall. Still, why not just stick to the basics? If it ain't broke, don't fix it.

Look, "Usability" simply refers to three overlapping (for better or worse) and mutually reinforcing core elements.

  • Effectiveness: the extent to which an application achieves its intended purpose, i.e., by capturing (and providing the capability for reporting back out) the requisite breadth of data;
  • Efficiency: the end-user operational task times-to-completion and associated error rates;
  • User experience/satisfaction: the more "subjective" / cognitive component. The extent to which using the app gives you a migraine or elevated BP.
Don't take my Great Unwashed word for it. See NISTIR 7714, issued just back in November (start with page 10).
 
See also "4.4. What Usability is Not" (pg 13 et seq).

"If usability is defined as above, it can be instructive to distance usability from some common misunderstandings.
  • Usability is not User Acceptance Testing (UAT). UAT involves taking use cases or procedures for how the system was designed to perform. and ensuring that someone who follows the procedure gets the intended result. That is, UAT examines whether the system is capable of performing all specified functions but not necessarily how well the system supports users in performing those functions..."
"UAT" rather precisely describes the ONC-ATCB HIT certification process, no? Read through the NIST Cert stds.

On the topic, check this out.

 
How We're Botching Our Attempts to Redesign the Healthcare System

- Roderick McMullen

Fixing our floundering healthcare system may be the single most complex design challenge ever. Bad design forced Dr. Bruce Mason (not his real name - BG), the clinical director of a large outpatient department at one of the preeminent teaching hospitals in the country, to force out one of the best doctors in his department. The doctor who was let go, Dr. Davis, didn’t violate the doctor’s code of ethics. He wasn’t old enough to retire. He hadn’t been sued for malpractice. In fact, he was a renowned practitioner.

Ultimately, Dr. Davis failed because he was unable to produce the required levels of documentation in the hospital’s version of an Electronic Health Record (EHR)...

Interesting.
___

LOOKING BACK ON "USABILITY":
THE LATE JEF RASKIN (father of AZA)

 The "father of the Macintosh interface"...
A summary of design rules
Jef Raskin

The first principle
.

When using a product to help you do a task, the product should only help and never distract you from the task.

Definition

A gesture is an action that you finish without conscious thought once you have started it. Example: For a beginning typist, typing the letter "t" is a gesture. For a more experienced typist, typing the word "the" is a gesture.

Commentary

Designing a human-machine interface demands that both the human and the machine be understood as well as possible. A understanding of the relevant portions of cognitive psychology, ergonomics, and cognetics is essential. That is not all that is needed, but it is a prerequisite.


Rule 1
.
An interface should be habituatingCommentary
If the interface can be operated habitually then, after you have used it for a while, its use becomes automatic and you can release all your attention to the task you are trying to achieve. Any interface will have elements that are habituating, but the principle here is to make the entire interface habituating.


Rule 1a
.
To make an interface habituating, it must be modeless
Commentary

Modes exist where the same gesture yields different results depending on system state at a time when your attention is not on system state. In the presence of modes, you will sometimes make mode errors, where you make a gesture intending to have one result but get a different and unexpected result, distracting you from your task.Rule 1b. To make an interface habituating, it must be monotonous. Commentary
"Monotony" here is a technical term meaning that you do not have to choose among multiple gestures to achieve a particular sub-task. Crudely, there should be only one way to achieve a single-gesture subtask.


The second principle
:
An interface should be reliable
Commentary

Aside from not crashing, the system should never lose any work you have done or any information you have received or retrieved, even if you make a mistake or are forgetful. This is often not thought of as a property of an interface, but one can build a reliable interface on top of an unreliable system (of the order of unreliability of todays operating systems).


Rule 2:
The system should neither lose your work nor through inaction allow your work to be lost.


The third principle

An interface should be efficient and as simple as possible.

Commentary

Time is an irreplaceable asset. An interface should not take more of your time than is necessary, either in use or in learning.


Rule 3

Good engineering practices should be applied to interface design. Quantitative measures should be used, and an interface should be close to its theoretical minimum in terms of the time it takes to do an operation.

Commentary

The GOMS model and information theoretic measures of efficiency (to name two particular techniques among many) must be mastered and used by interface designers. Another set of techniques and measures can be used to help judge learnability.


The fourth principle
The suitability of an interface can only be determined by testing.

Commentary

All of the theory in the world, and the wisest guru, cannot always predict how an interface will work in practice. One must test, objectively observe, and modify the interface if testing shows that users have difficulties. It is never the user's fault, but also remember that people find it difficult to change, so difficulties based on previous habits may not be dispositive.


The fifth principle
An interface should be pleasant in tone and visually attractive.
Commentary

How messages are phrased is important, how the interface looks is also important. But these are of secondary importance in terms of task completion. When use of the interface has become habitual, these elements go unnoticed. All of the principles, if followed, create learnable interfaces.


Summary

An interface should be effective, habituating, reliable, efficient, and tested. To the extent that doing so does not conflict with these essentials, an interface should also be attractive.

See also

___

Usability. Not exactly a new topic. But, it'll be interesting to see how ONC will manage to develop and administer appropriate EHR "usability" certification standards this year and incorporate them into the already hugely contentious proposed Stage 2 Meaningful use criteria (and concomitant HIT vendor "UAT" re-certification).


It's worth keeping in mind that the maximum MU reimbursement incentives are skewed in favor of the earliest participants, and decline year after year (e.g., below, example on the Medicare provider side), so, at the same piling on more complex and operationally onerous requirements will indeed comprise a challenge to the long-term viability of the program (and this assumes Congress won't be able to rescind the MU money now on the table).


March 3rd a.m. news update:
Meaningful use updates available by e-mail
Physicians and health care organizations can sign up with CMS for news about the payment process and tips on wading through the incentive program.
By PAMELA LEWIS DOLAN, amednews staff. Posted March 3, 2011.
___

OFF ON A BIT OF A TANGENT, JUST 'CAUSE

 Ah, the jousting within science, e.g., the "Frequentist" vs the "Bayesian" (count me in the latter camp, net).

As I've noted, one of my favorite daily hangs is sciencebasedmedcine.org. Apropos of "Evidence-Based Medicine" (EBM), I love this March 4th post:

Of SBM and EBM Redux. Part IV, Continued: More Cochrane and a little Bayes...

Bayes Revisited
A few years ago I posted three essays about Bayesian inference... The salient points are these:

  1. Bayes’s Theorem is the solution to the problem of inductive inference, which is how medical research (and most science) proceeds: we want to know the probability of our hypothesis being true given the data generated by the experiment in question.
  2. Frequentist inference, which is typically used for medical research, applies to deductive reasoning: it tells us the probability of a set of data given the truth of a hypothesis. To use it to judge the probability of the truth of that hypothesis given a set of data is illogical: the fallacy of the transposed conditional.
  3. Frequentist inference, furthermore, is based on assumptions that defy reality: that there have been an infinite number of identically designed, randomized experiments (or other sort of random sampling), without error or bias.
  4. Bayes’s Theorem formally incorporates, in its “prior probability” term, information other than the results of the experiment. This is the sticking point for many in the EBM crowd: they consider prior probability estimates, which are at least partially subjective, to be arbitrary, capricious, untrustworthy, and—paradoxically, because it is science that is ignored in the breach—unscientific.
  5. Nevertheless, prior probability matters whether we like it or not, and whether we can estimate it with any certainty or not. If the prior probability is high, even modest experimental evidence supporting a new hypothesis deserves to be taken seriously; if it is low, the experimental evidence must be correspondingly robust to warrant taking the hypothesis seriously. If the prior probability is infinitesimal, the experimental evidence must approach infinity to warrant taking the hypothesis seriously.
  6. Frequentist methods lack a formal measure of prior probability, which contributes to the seductive but erroneous belief that “conclusions can be produced…without consideration of information from outside the experiment.”
  7. The Bayes Factor is a term in the theorem that is based entirely on data, and is thus an objective measure of experimental evidence. Bayes factors, in the words of Dr. Goodman, "show that P values greatly overstate the evidence against the null hypothesis."
Awesome. I've cited Bayes before, e.g.,
 As I wrote, "Relax, it's only algebra."
  • Let p(t|+) = the probability of being a true positive ("t") given a positive test finding (+);
  • Let p(+|t) = the probability of testing positive (+) given that you are in fact a "t";
  • Let p(t) = the "prevalence" of true positives, e.g., the proportion of true positives in the aggregate population;
  • Let p(+|f) = the probability of testing positive (+) given that you are in fact NOT a "t" (i.e., the false positive rate);
  • Let p(f) = 1 - p(t), the proportion of true negatives in the population.
A concrete example:


It goes to both the empirically established "accuracy" of a test (how reliably it can return the value of a known reference standard) and the "prevalence" (proportion) of true positives in a population. Not widely enough understood. In practical terms, should you test "positive" for some rare condition, you might want to question the extent of the "known accuracy" of the assay (and how much it varies in production from lab to lab) before getting all bent out of shape (ruminate on #5 above). There's a danger, particularly in light of the new national push for HIT-enabled CER, for those (both researchers and patients) who take lab results at face value.

"[P]rior probability matters whether we like it or not, and whether we can estimate it with any certainty or not."
Indeed.
___

AND THE HITS JUST KEEP ON COMING...


Click above for the full article.

Hans Rosling's 200 Countries,
200 Years, 4 Minutes - The Joy of Stats - BBC Four


From poor and sick to healthy and wealthy.



Pretty cool. Go to Gapminder.org for more.
___

APROPOS OF WHERE THIS POST STARTED,
COOL BOOK

Props to my email correspondent pal health care Futurist Joe Flower for turning me on to this awesome, radically simple yet profound book.


[ click the book cover image for the author's website ]

While I wish I'd read it prior to giving my Touro University presentation, I'm gratified to know that I'd intuitively gotten some of the Jobsian presentation principles right, -- i.e., [Numero Uno] attempt to answer the audiences' question "why should I care about any of this?" right at the outset (i.e., "what's in this for me?"). Then build your case via a "story," using core "story" principles: Conflict, Villain(s), Hero, and Resolution.

Yeah. A widely known trial lawyer maxim is 'he/she with the best story wins."Keep it simple. Headline that could fit in a Twitter post. The Power of Three. Zen. Less Is More. No bullet lists. Use images. Use props. Eye contact. Body language. Vocal inflection variations. Never Let Them See You Sweat (i.e., woodshed your material so much that it's virtually autopilot for you, so the likelihood of sweating it out is next-to-nil). Be self-deprecating. Have fun.

Highly recommended read. Everyone in my REC (and ONC) ought to read this book. There are also a number of nice summary / reinforcing YouTube clips online, e.g..
BTW, Joe also recommended to me "Presentation Zen," which I already had in my book stash.
___